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Association between interleukin-6 and carotid atherosclerosis diovascular disease. A significant increase in the intima-
in hemodialysis patients. media thickness of the carotid artery is reported in dial-
Background. Interleukin-6 (IL-6) is associated with cardio- ysis patients compared to age-matched healthy subjectsvascular complications in general subjects. Although blood IL-6
by echography [2–4]. However, which factor is involvedis greatly elevated in hemodialysis (HD) patients, the role of
in the facilitation of atherosclerosis in HD patients re-IL-6 in the advance of atherosclerosis remains to be determined.
Methods. We conducted a cross-sectional study to investi- mains undetermined.
gate the relationship between circulating IL-6 and carotid ath- Recently, high blood C-reactive protein (CRP), a
erosclerotic changes in 156 HD patients (age 58  1 years; marker of inflammation, is demonstrated as a powerfultime on HD treatment 13  1 years; 97 males and 59 females).
predictor for the mortality in HD patients [4–9]. IsekiSerum IL-6, IgG and IgA titers of Chlamydia pneumoniae anti-
et al reported that HD patients with serum CRP morebodies, the intima-media thickness (IMT) and the cross-sec-
tional intima-media area (IMarea) of the carotid arteries were than 1.0 mg/dL had a significantly higher mortality rate
measured by ultrasonography in each patient. during seven years compared to those with serum CRP
Results. Serum IL-6 levels were significantly higher in HD
values less than 1.0 mg/dL [5]. Zimmermann et al alsopatients (2.04 0.16 pg/mL) compared to normal age-matched
found that increased CRP levels more than 0.75 mg/dLcontrol subjects (0.31  0.06 pg/mL, N  24). Circulating log
IL-6 levels were positively correlated with IMT (r  0.278, induced a 2.7-fold higher mortality risk than those less
P  0.01) and IMarea (r  0.344, P  0.01), respectively. A than 0.33 mg/dL for the two-year observation period in
stepwise multiple regression analysis revealed that IL-6 became 280 HD patients [6]. They found that cardiovascular
significant predictors for IMT and IMarea but not for aortic
mortality was much higher in patients with elevatedwall calcification at L2/3 vertebrae. Serum log IL-6 was signifi-
CRP. In addition, Stenvinkel et al noticed a greater prev-cantly correlated with IgG (r 0.277, P 0.01) and IgA titers
of anti-Chlamydia antibodies (r 0.192, P 0.02). Serum IgA alence of carotid plaques and a more increase in cross-
anti-Chlamydia titers were also correlated with the maximal sectional carotid intima-media area in pre-dialysis pa-
diameter of carotid plaque (r  0.293, P  0.04). tients with elevated CRP more than 1.0 mg/dL [4]. TheseConclusions. These findings suggested that IL-6 is associated
findings convincingly suggest a close relationship be-with the severity of carotid atherosclerosis in HD patients. Per-
tween inflammation and atherosclerotic changes andsistent chronic chlamydial infection may be related, in part, to
the advance of carotid plaque enlargement in dialysis patients. mortality in dialysis patients.
Interleukin-6 (IL-6) is one of the most potent pro-
inflammatory cytokines that initiates the acute phase
It has been passed over 35 years to start hemodialysis response by hepatocytes and induces the synthesis of
(HD) therapy for the treatment of uremia, but the mor- CRP [10]. In the general elderly, elevation of circulating
tality rate in dialysis patients remains several-fold higher IL-6 has been demonstrated to be associated with cardio-
compared to general population [1]. One of the major vascular mortality [11]. High serum IL-6 levels at admis-
causes of mortality and morbidity is atherosclerotic car- sion were also related to the subsequent in-hospital acute
coronary syndrome in patients with unstable angina [12].
In addition, the presence of IL-6 mRNA and proteinsKey words: Chlamydia pneumoniae, atherosclerosis, IL-6, soluble TNF
receptor, hemodialysis, carotid artery, uremia, cardiovascular disease. was detectable in coronary plaque samples obtained
from patients undergoing heart transplantation or ather-Received for publication July 9, 2001
ectomy [13], possibly indicating a putative role of IL-6and in revised form September 14, 2001
Accepted for publication October 11, 2001 for the development of atherosclerosis. In HD patients,
serum IL-6 level is known to be much higher than general 2002 by the International Society of Nephrology
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subjects, and associated with mortality, malnutrition and of 180 to 220 mL/min. All patients used bicarbonate dialy-
sate (30 mEq/L, Kindaly AF-2P; Fuso, Osaka, Japan) aterythropoietin resistance [14–18]. However, it remains
undetermined if high IL-6 may be associated with the a dialysis flow rate of 500 mL/min. All HD treatments
were performed using one of the following membranes:progression of atherosclerosis in dialysis patients.
Recently, persistent chronic infection with Chlamydia low-flux ultrafiltration rate (UFR20 mL/min · h) modi-
fied regenerated cellulose hollow-fiber (MRC: AM-SD,pneumoniae has been demonstrated as one of the impli-
cated organisms of cerebrovascular disease [19, 20]. Ele- Asahi Medical, Tokyo, Japan; or CL-EE, Terumo, Tokyo,
Japan), medium-flux (UFR 20 to 40 mL/min · h) cellu-vation of Chlamydia IgA antibodies is associated with the
increment of long-term cardiovascular mortality in gen- lose triacetate hollow-fiber (CTA: FB-U, Nipro Medical,
Osaka, Japan; or TFW, Teijin-Gambro, Tokyo, Japan)eral subjects [20]. In dialysis patients, a significant higher
prevalence of Chlamydia pneumoniae DNA was noticed and high-flux (UFR 40 mL/min · h) polysulfone syn-
thetic hollow-fiber (PS: BS-U, Toray Medical, Tokyo, Ja-compared to healthy blood donors (16.3 vs. 8.5%) (ab-
stract; Muller et al, J Am Soc Nephrol 11: 290A, 2000). pan; or APS, Asahi Medical, Tokyo, Japan). All patients
had been using the same dialyzer membrane for moreThe association between the number of carotid plaques
and IgG anti-Chlamydia antibodies has been demon- than one year. No patient re-used the dialyzer mem-
brane, per standard practice in Japan. Neither bacteriastrated in HD patients [21]. A significant positive relation-
ship between IgA titer and intima-media area (IMarea) nor pyrogen was detected in the dialysate prepared from
water obtained by reverse osmosis. By endotoxin re-also was shown in pre-dialysis chronic renal failure pa-
tients [22]. In addition, seropositivity for IgA antibody moval filter, the endotoxin concentration in the dialysate
was below 20 EU/L by routine analysis with Limuluswas associated with the reduced survival rate by cardio-
vascular complications during a six-year follow-up study amebocyte lysate assay (Wako Junyaku endotoxin mea-
surement kit, Tokyo, Japan) in all patients. Blood sam-in patients on peritoneal dialysis [23].
The aim of our present study was to investigate the ples were drawn from the arterial site of the arteriove-
nous fistula at the start and at the end of dialysis sessionrelationship between circulating IL-6 and the severity of
atherosclerotic changes in patients receiving long-term after the two-day interval. Serum was transferred into
plastic tubes and stored at82C until the measurement.HD. We cross-sectionally determined the intima-media
thickness (IMT), the cross-sectional intima-media area The efficiency of the dialysis was assessed based on urea
reduction rate (URR), calculated from the monthly blood(IMarea) of the carotid arteries and the degree of aortic
wall calcification, respectively. We also measured serum tests based on the formula (1  post-BUN/pre-BUN) 
100, and the delivered dose of dialysis (Kt/Vurea) using atiters of IgG and IgA antibodies for Chlamydia pneu-
moniae, and examined the association between circulat- single-pool urea kinetic model. Protein catabolic rate
(PCR), an indirect indicator of protein intake, was calcu-ing IL-6 and Chlamydia pneumoniae antibody titers.
lated from dialysis urea removal and serum urea levels.
METHODS Analytical procedures
Study population Serum urea nitrogen, creatinine, total protein, albu-
min, total cholesterol, high-density lipoprotein (HDL)-One hundred fifty-seven clinically stable patients from
a single dialysis unit (Maruyama Hospital) were ran- cholesterol and hemoglobin were measured by standard
laboratory techniques using an automatic analyzer. C-reac-domly selected. The patients comprised of 97 male and
59 female with a mean age of 58  1 (range 28 to 89) tive protein was measured by laser nephelometer.
Serum IL-6 level was determined by enzyme-linked im-years. The mean time on HD treatment was 13  1
years, ranging from 3 to 30 years. Patients with infectious munosorbent assay (ELISA; Human IL-6 Ultrasensitive
ELISA, Biosource International, Camarillo, CA, USA).complications within six months were excluded. The
causes of end-stage renal failure were primary renal dis- The coefficient of intra-assay IL-6 variation in replicates
of four samples was 4.5% in our study. The coefficientease in 138 (88%) patients and diabetes in 18 (12%)
patients. Residual urine outputs were within 200 mL/ of inter-assay variation in two different kits was also
within 10%. Blood tumor necrosis factor- (TNF-) andday in all patients. The life-long dose of smoking was
calculated as Brickman index (BI), which uses data from soluble TNF receptor p55 (sTNFR p55) were measured
in 40 randomly selected patients by commercial ELISAyears of smoking history and daily number of cigarettes.
This study was restricted to steady, non-disabled dialysis kit [Quantikine HS Human TNF- Immunoassay; R&D
Systems, Minneapolis, MN, USA; and sTNFR (55 kD)patients, which simplified the interpretation of the data.
ELISA, Bender MedSystems, Vienna, Australia].
Hemodialysis-related factors IgG- and IgA-specific antibodies for Chlamydia pneu-
moniae were tested using the ELISA kit (Hitazyme Chla-All patients had been subjected to a regular HD for four
to five hours for three times per week at a blood flow rate mydia pneumoniae Ab-IgG, Ab-IgA; Hitachi-Kasei,
Kato et al: IL-6 and carotid intima-media changes 1145
Tokyo, Japan). This test can selectively detect the anti- computed tomography (CT) slice between the second
and third lumbar vertebrae, because the degree of calci-gen of chlamydial outer membrane complex of the ele-
mentary body. The sensitivities of IgG and IgA antibod- fication was the most remarkable in this region [26].
The pre-dialysis mean blood pressure (MBP) was de-ies were 87.5% and 72.7%, and the specificities for IgG
and IgA antibodies were 95.7% and 93.1%, respectively. termined as MBP  diastolic 	 (systolic  diastolic)/3.
Atherosclerotic index (AI) was calculated as AI (totalThe cut-off value distinguishing between positive and
negative samples was calculated from the formula: cut off cholesterol  HDL-cholesterol)/HDL-cholesterol [27].
Low-density lipoprotein (LDL)-cholesterol was calcu-value (COV)  (CN K)	 0.20, where CN is the mean
value of negative control serum adsorbance at 405 nm in lated from modified Friedewald’s formula for the Japa-
nese population (total cholesterolHDL-cholesterolduplicate, and K is the ratio of the positive serum sample
value to the mean values of positive control serum ad- triglyceride/4) [28].
sorbance at 405 nm. Seropositivity of IgG and IgA for
Statistical analysisChlamydia pneumoniae was defined as the cut-off index
(COI) 1.10, where COI represents the ratio between Each value was expressed as the mean  SE. Differ-
ences between two groups were analyzed by the unpairedabsorbance of sample at 450 nm  K and the COV.
Student t test following analysis of variance (ANOVA).
Evaluation of atherosclerotic changes P values less than 0.05 were considered statistically sig-
nificant. A stepwise multiple regression analysis was ap-The right and left carotid arteries were examined using
a 7.5 Hz linear array transducer with high-resolution plied to examine the relationship between atheroscle-
rotic changes (IMT, IMarea, the presence of carotidB-mode echography (Aloka, Tokyo, Japan). This device
can measure the arterial wall thickness by 0.1 mm. Sub- plaque, %ACI) and a set of clinical parameters including
age, sex, diabetes, time on HD treatment, smoking, meanjects were in the supine position with the head slightly
turned from echography at the measurement. All scan- blood pressure (MBP), log IL-6, creatinine, albumin,
intact parathyroid hormone (PTH), calcium  phos-nings were performed by the same investigator. The wall
of the common carotid artery, 0.5 to 1.0 cm proximal phate, magnesium, log CRP, titer of IgG anti-Chlamydia
antibody, titer of IgA anti-Chlamydia antibody, AI andto the beginning of the carotid bulb, was used for the
measurement of the intima-media thickness (IMT) and Kt/Vurea. Since IL-6 and CRP were non-normally distrib-
uted in this study, we normalized these data by log trans-lumen diameter. The IMT was defined as the distance
between the leading edge of the lumen-intima echo of formation before entering a stepwise multiple regression.
We also used log-transformed TNF- when the associa-the near wall and the leading edge of the media-adventi-
tia echo. The lumen diameter was defined as the distance tion was examined. The significant independent variables
were ordered according to their standardized effect, de-between the leading edge of the intima-lumen echo of
the near wall and the leading edge of the lumen-intima fined as regression coefficient/standard error of the re-
gression (
). All statistical calculations were performedecho of the far wall. To enhance the reproducibility of
carotid measures, standardized interrogation angles were with the GB-STAT software (Dynamic Microsystems,
Silver Spring, MD, USA).used according to the recommendations described as pre-
viously [24]. The mean values of the IMT and lumen di-
ameter were calculated from at least two measurements
RESULTS
for each artery. The cross-sectional intima-media area
Serum IL-6 and clinical parameters(IMarea) of the carotid artery was calculated using the
following formula; 3.14 [(lumen diameter/2	 IMT)2 Mean serum IL-6 levels were significantly higher in
HD patients (2.04  0.16 pg/mL; range 0.24 to 16.04;(lumen diameter)2], which is known to be unaffected by
variations in artery distension secondary to changes in median 1.40 ng/mL; N  156) compared to healthy age-
matched control subjects (0.31  0.06 pg/mL; range;blood pressure [4, 24]. This cross-sectional IMarea has
proven to be a much better predictor of coronary athero- 0.00 to 1.17; median 0.19 pg/mL; age 53  3 years; male/
female ratio 14/10; N  24; P  0.01). There was asclerosis than IMT [25]. The existence of carotid plaque,
which is defined as the intima-media thickening of more significant positive relationship between serum log IL-6
values and age (r  0.323, P  0.01) or time on HDthan 1 mm, was screened for in the common, internal, and
external carotid arteries. We also determined the maximal treatment (r  0.180, P  0.03). No significant associa-
tion was found between IL-6 and the prevalence of sexdiameter of carotid plaque along the artery wall.
Electrocardiogram (ECG) was recorded just before the and smoking. IL-6 was significantly and positively cor-
related with CRP after normalizing by log transforma-starting of dialysis. The presence of abnormal Q or inverted
T wave in extremity leads was defined as ischemic ECG tion (r  0.382, P  0.01). There was no relationship
between log IL-6 and dialysis efficacy such as Kt/Vureachanges. The percentile of calcification index (%ACI) in
the abdominal aortic wall was measured at the horizontal and URR values.
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Table 1. Comparison of patient characteristics by circulating interleukin-6 (IL-6) level
Variable Group 1 Group 2 Group 3
Blood IL-6 pg/mL 1.1 1.1  IL-6  2.0 2.0
Mean IL-6 pg/mL 0.740.03 1.510.03 4.100.35
N 53 54 49
Patient’s profile
% Male 71.7 72.2 53.1
Age years 552 591 621b
Time on HD treatment years 12.61.1 12.30.9 15.31.0c
Prevalence of diabetes % 9.4 11.1 14.3
Prevalence of smoking habits % 39.2 50.0 34.7
Brickman index 15037 25345 18852
Dialysis-related factors
Urea nitrogen mg/dL 75.91.8 77.22.0 71.21.5c
Calcium mEq/L 4.60.1 4.70.1 4.60.04
Phosphate mg/dL 6.10.2 6.20.2 5.50.2a
Magnesium mg/dL 3.00.1 3.00.1 2.90.1
Intact PTH pg/mL 17827 368132 18137
Kt/Vurea 1.250.02 1.240.03 1.300.03
URR % 70.50.9 70.31.0 72.51.2
Hemoglobin g/dL 10.40.1 10.50.2 10.30.2
CRP mg/dL 0.190.04 0.190.03 0.940.38ac
Nutrition-related factors
Creatinine mg/dL 12.50.3 12.40.2 10.70.3bd
Albumin g/dL 3.90.05 3.80.03 3.70.04b
Total cholesterol mg/dL 1535 1574 1535
PCR g/kg/day 1.040.02 1.050.02 1.000.02
Abbreviations are: HD, hemodialysis; PTH, parathyroid hormone; URR, urea reduction rate; CRP, C-reactive protein; PCR, protein catabolic rate. Data are
expressed as means  standard error.
a P  0.05, b P  0.01 vs. group 1
c P  0.05, d P  0.01 vs. group 2
All patients were divided into three groups according (r 0.504, P 0.01; Fig. 2). Circulating log IL-6 concen-
to their IL-6 values: group 1, IL-6 in the bottom third tration was significantly and positively correlated with
for all patients (IL-61.1 pg/mL, N 53), group 2, IL-6 IMT (r  0.278, P  0.01) and IMarea (r  0.334, P 
in the middle third (1.1  IL-6  2.0 pg/mL, N  54) 0.01), respectively (Fig. 3). A significant linear associa-
and group 3, IL-6 in the top third of the population (IL-6 tion was found between log IL-6 and IMT or IMarea
2.0 pg/mL, N  49). The mean age was significantly both in diabetic (IMT, r  0.606, P  0.01; IMarea, r 
older in patients of group 3 compared to those of group 1 0.630, P 0.01; N 18) and non-diabetic patients (IMT,
(P  0.01; Table 1). The time on HD was also signifi- r  0.218, P  0.01; IMarea, r  0.305, P  0.01, N 
cantly longer in group 3 compared to group 2 (P 0.05). 138). In contrast, log IL-6 was not associated with AI
In contrast, the prevalence of sex, diabetes or smoking and %ACI values. Log IL-6 also did not correlate with
was identical among all groups. There was also no differ- HDL-cholesterol. Serum log-transformed TNF- level
ence in intact PTH, hemoglobin, Kt/Vurea and URR val- (12.70  0.62 pg/mL; range 9.45 to 22.51; median 11.85
ues in three groups. Mean serum CRP was significantly pg/mL; N  40) also correlated with IMT (r  0.370,
higher in group 3 (P  0.05), but within normal limits P  0.02), IMarea (r  0.563, P  0.01) and %ACI
(0.5 mg/dL) in groups 1 and 2. (r  0.516, P  0.01), respectively. However, circulating
Serum creatinine concentrations were significantly sTNFR p55 (26.8  0.7 ng/mL; range 14.0–35.3; N  40)
lower in group 3 compared to groups 1 and 2, respectively did not correlate with these parameters. Serum albumin
(P 0.01, Table 1). Serum albumin also was significantly
level also was inversely correlated with IMarea (r reduced in patients with IL-6 in the top third compared
0.250, P  0.01) but not IMT.with those in the bottom third (P  0.01). Serum log
Both IMT and IMarea were more prominent in pa-IL-6 levels were significantly and inversely correlated
tients with IL-6 more than 2.0 pg/mL than those withwith serum albumin (r0.328, P 0.01) or creatinine
IL-6 less than 1.1 pg/mL (P 0.01, Table 2). The degree(r  0.297, P  0.01; Fig. 1). In contrast, there was no
of %ACI was more severe in patients with IL-6 in thedifference in total cholesterol and PCR values among
top third (P 0.01). In addition, the prevalence of ische-all groups.
mic ECG changes was significantly more prominent in
Serum cytokine and atherosclerotic changes group 3 than group 1 (Table 2). In contrast, there was
no difference in the prevalence of carotid plaque in allThere was a significant linear positive relationship be-
tween age and IMT (r  0.453, P  0.01) or IMarea groups. No significant difference was found in mean blood
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Fig. 1. Relationship between log interleukin-6
(IL-6) and serum albumin (A) and creatinine
(B). Serum log IL-6 levels were significantly
and inversely correlated with serum albumin
(r  0.328, P  0.01) or creatinine (r 
0.297, P  0.01).
Fig. 2. Relationship between age and carotid
intima-media thickness (IMT) or carotid cross-
sectional intima-media area (IMarea). A sig-
nificant linear relationship was found between
patient’s age and IMT (r  0.453, P  0.01)
or IMarea (r  0.504, P  0.01).
Fig. 3. Association between circulating log IL-6
and carotid intima-media thickness (IMT) or ca-
rotid cross-sectional intima-media area (IMarea)
in dialysis patients. There was a significant posi-
tive relationship between log IL-6 and IMT
(r  0.278, P  0.01) or IMarea (r  0.344,
P  0.01).
Table 2. Atherosclerotic and chlamyidal parameters in all groups
Variable Group 1 Group 2 Group 3
Blood IL-6 pg/mL 1.1 1.1  IL-6  2.0 2.0
N 53 54 49
Atherosclerosis-related factors
Mean blood pressure mm Hg 1092 1132 1132
Atherogenic index 3.60.2 3.60.3 3.50.2
LDL cholesterol mg/dL 844 914 834
HDL cholesterol mg/dL 351 351 341
Triglyceride mg/dL 13711 1279 14315
Ischemic ECG changes % 28.3 33.3 53.1a
%ACI at L2/3 15.63.8 23.63.0 30.44.2a
IMT mm 0.590.01 0.620.02 0.660.02b
IMarea mm2 14.60.6 15.70.7 17.50.7b
Prevalence of carotid plaque % 24.5 35.2 36.7
Maximal plaque diameter mm 3.10.4 3.10.3 3.10.3
Chlamydia-related factors
Seropositivity for IgA % 45.3 51.9 58.3
Seropositivity for IgG % 52.8 67.9 63.2
IgA antibody titer 1.030.11 1.240.12 1.360.13a
IgG antibody titer 1.110.11 1.390.10 1.590.13b
Abbreviations are: LDL, low density lipoprotein; HDL, high density lipoprotein; ECG, electrocardiogram; %ACI, percentile calcification of aortic wall; IMT,
carotid intima-media thickness; IMarea, cross-sectional intima-media area. Data are expressed as means  standard error.
a P  0.05, b P  0.01 vs. group 1
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Table 3. Results of stepwise multiple regression analysis of
the carotid intima-media thickness, the carotid cross-sectional
intima-media area, the presence of carotid plaque, and the
percentile calcification of aortic wall for the
determinants of independent factors
Dependent variable

 F value
Intima-media thickness
Multiple R  0.510
F-to-remove  4.00, P  0.0001
Independent variables
Age 0.52 32.60
log IL-6 0.23 8.34
Albumin 0.22 5.86 Fig. 4. Relationship between serum IgA antibody titer for Chlamydia
Intima-media area pneumoniae and maximal diameter of carotid plaque. There was a sig-
Multiple R  0.524 nificant and linear association between IgA antibodies and maximal
F-to-remove  4.00, P  0.0001 plaque diameter by sonography (r  0.293, P  0.04). The dotted line
Independent variables denotes the cut-off value.
Age 0.47 33.36
Mean arterial blood pressure 0.22 8.20
log IL-6 0.17 4.43 with Chlamydia pneumoniae antibody-positive patients
Presence of carotid plaque
compared to negative patients (IgG, 249  38 vs. 124 Multiple R  0.496
F-to-remove  4.00, P  0.0001 29, P  0.02; IgA, 250  40 vs. 144  31, P  0.05).
Age 0.35 16.17 There was no difference in IMT and IMarea values
%ACI
between in IgG seropositive and seronegative patientsMultiple R  0.580
F-to-remove  4.00, P  0.0001 (IMT, 0.63  0.02 vs. 0.62  0.02 mm, P  NS; IMarea,
Age 0.49 24.30 16.0  0.5 vs. 15.8  0.5 mm2, P  NS). The prevalence
Male 0.30 9.42 of carotid plaque was identical also between in IgG sero-Diabetes 0.21 4.42
positive and seronegative patients (29.5 vs. 36.6%, P 
Abbreviations are: IL-6, interleukin-6; %ACI, the percentile calcification of
NS). No significant difference was found in IMT andaortic wall; 
, standardized regression coefficient.
IMarea between in IgA positive and negative patients
(IMT, 0.62  0.02 vs. 0.62  0.01 mm, P  NS; IMarea,
pressure and LDL-cholesterol values among the three 15.6  0.6 vs. 16.2  0.5 mm2, P  NS). The prevalence
groups. of carotid plaque was identical between IgA seropositive
A stepwise multiple regression analysis revealed that and seronegative patients (32.5 vs. 32.4%, P  NS). In
log IL-6, age and albumin were independent factors for addition, no association was found between chlamydial
the length of IMT (Table 3). Similarly, log IL-6, age and seropositivity and the prevalence of ischemic ECG
mean arterial pressure became significant determinants changes.
for the width of IMarea (Table 3). In contrast, the pres- In contrast, the maximal diameter of carotid plaque
ence or absence of carotid plaque was only dependent was significantly larger in patients positive to IgA anti-
upon age. Patient’s age, the prevalence of diabetes and Chlamydia antibody (3.5  0.2 mm, N  26) compared
sex also became significant predictors for the severity of to negative patients (2.7 0.3 mm, N 24; P 0.03). The
%ACI (Table 3). degree of %ACI was also severe to a greater extent in IgA
positive patients compared to negative patients (27.7 Serum Chlamydia antibodies and atherosclerosis
3.1 vs. 18.2  3.3%, P  0.04). A linear relationship was
IgG and IgA anti-Chlamydia antibodies were detect- found between serum IgA titers and maximal carotid
able in 61.3% and 51.6% of our HD patients, respectively. plaque diameter (r  0.293, P  0.04, N  50, Fig. 4).
The mean titers of IgG and IgA antibodies to Chlamydia
Association between IL-6 and chlamydial seropositivitypneumoniae in seropositive patients were 1.89  0.06
(1.10 to 3.87) and 1.86 0.07 (1.10 to 3.65), respectively. The prevalence of IgG or IgA Chlamydia seropositiv-
There was no difference in age and time on HD treat- ity was identical among the three groups (Table 2). How-
ment between seropositive and seronegative patients. ever, there was a significantly higher titer of IgG (P 
The prevalence of male was significantly higher in IgG 0.01) and IgA (P  0.05) chlamydial antibodies in pa-
antibody positive patients compared to negative patients tients with IL-6, more than 2.0 pg/mL compared to those
(72.6 vs. 56.7%, P 0.05). The prevalence of smoking hab- less than 1.1 pg/mL (Table 2). Serum log IL-6 levels were
its was significantly more frequent in patients with positive weakly but significantly and positively correlated with
IgG antibody (71.9 vs. 53.9%, P  0.03). In contrast, IgA serum titers of IgG antibody (r 0.277, P 0.01) and IgA
seropositivity was not associated with the prevalence of antibody (r  0.192, P  0.02), respectively (Fig. 5).
Serum chlamydial titers were also significantly correlatedsex or smoking. BI was significantly higher in patients
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Fig. 5. A positive relationship between serum
log IL-6 and IgG, or IgA titers of Chlamydia
pneumoniae. A significant positive relation-
ship was existed between log IL-6 and IgG
antibodies (r  0.277, P  0.01) or IgA anti-
bodies (r  0.192, P  0.02) to Chlamydia
pneumoniae.
with log IL-6 in diabetic patients (IgG, r  0.442, P  revealed that log IL-6 was a significant independent de-
0.07; IgA, r  0.506, P  0.03, N  18). In contrast, terminant for IMT and IMarea. These findings collec-
there was no significant association between serum CRP tively suggested that higher IL-6 could be associated with
values and the titers of Chlamydia IgG and IgA antibod- the severity of coronary atherosclerosis in our patients.
ies in our patients. Serum TNF- and sTNFR p55 levels Elevated IgA antibody to Chlamydia pneumonia is
also did not correlate with serum IgG and IgA titers (data considered as a sign of a chronic and still active infectious
not shown). process, whereas IgG antibody may represent a marker
of a past exposure since IgG titers decrease slowly after
an acute infection. In this study, the serum IgA titer wasDISCUSSION
correlated with the maximal carotid plaque diameter. In
Interleukin-6 is a potent circulating cytokine secreted contrast, we failed to detect any significant association
from a number of different cells such as activated macro- between the titers and the severity of carotid wall thick-
phages and lymphocytes [29]. IL-6 is demonstrated to ness. These findings indicate that a persistent chlamydial
increase the risk of atherosclerosis through metabolic, infection might affect the advance of carotid plaque en-
endothelial and coagulant mechanisms [30]. For instance, largement rather than carotid wall thickening in long-
IL-6 increases basal glucose uptake, alters insulin sensi-
term HD patients.
tivity, and increases the hepatic release of fibrinogen as
Interleukin-6 is known to be associated with the sever-well as having procoagulant effects of platelet, which
ity of hypoalbuminemia and renal anemia in HD patientspromotes atherogenic processes [30]. IL-6 also stimulates
[14–18]. Our study found that log IL-6 was negativelythe release of soluble intercellular adhesion molecule-1
correlated with serum albumin and creatinine levels, sug-by the endothelium, a marker of future myocardial in-
gesting the existence of malnutrition in patients with highfarction in normal men [31]. IL-6 may stimulate hepatic
IL-6. A multiple regression analysis also revealed thatsynthesis of ceruloplasmin-bound copper and serum am-
albumin was a significant determinant for IMT. Ikizleryloid A, subsequently altering HDL structure and func-
et al demonstrated that the nutritional status and in-tion and eliminating its ability to reduce oxidized LDL
flammatory response become independent predictors of[32]. Fibrous plaques obtained from human iliac arterial
hospitalization in HD patients [36]. The presence of hy-walls are also shown to possess higher IL-6 proteins and
poalbuminemia also is associated with a higher complica-gene expression [33]. In addition, elevation of IL-6 is
tion of cardiovascular disease in dialysis patients [37].demonstrated as an independent risk factor for the future
Recently, Stenvinkel et al proposed the existence of amyocardial infarction among apparently healthy subjects
syndrome consisting of malnutrition, inflammation and[11, 34]. These findings suggest a putative role of IL-6
atherosclerosis (MIA syndrome) in some patients withfor the initiation and progression of atherosclerosis.
chronic renal failure [38]. Kaysen also reviewed the roleIn dialysis patients, elevation of circulating IL-6 was re-
of inflammation as a primary cause of malnutrition andlated to higher mortality rate during a 1000-day follow-up
vascular disease in uremic patients [32]. Taken together,study [14]. A positive correlation was found between
it is therefore likely that elevation of IL-6 may play aserum IL-6 and lipoprotein (a), or fibrinogen values in
central role for the close relationship between the highchronic HD patients [35]. Our current results found that
prevalence of inflammation, malnutrition and cardiovas-serum log IL-6 was positively correlated with the severity
cular disease in HD patients.of carotid atherosclerosis including IMT and IMarea both
In this study, we found a significant relationship be-in diabetic and non-diabetic patients. Patients with serum
tween blood IL-6 and IgG or IgA titers for ChlamydiaIL-6 more than 2.0 pg/mL had a greater prevalence of
pneumoniae. In a general population of patients, a puta-ischemic ECG changes compared to those with IL-6 less
than 1.1 pg/mL. A stepwise multiple regression analysis tive relationship between IL-6 levels and chlamydial IgA
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titers has been suggested [39–41]. For example, IgA titers of Chlamydia pneumoniae antibodies did not correlate
with serum log TNF- and sTNFR p55 levels in this study.were positively correlated with circulating IL-6 levels in
patients with acute myocardial infarction [39]. Acellular The hepatic synthesis of CRP is largely regulated by
IL-6 [51]. Elevation of serum CRP is demonstrated tocomponents of Chlamydia pneumoniae can directly stim-
ulate IL-6 production in human blood mononuclear cells be strongly associated with carotid atherosclerosis, fu-
ture risk of cardiovascular disease and mortality in nor-in vitro [40]. Chlamydial infection also elicits IL-6 pro-
duction from human smooth muscle cells [41]. It is there- mal and dialysis patients [4–9]. However, we only found
a weak association between log CRP and IMarea (r fore likely that chronic chlamydial infection, in part, may
influence circulating IL-6 levels. However, we could not 0.144, P  0.096). This discrepancy between the present
study and the previous studies remains unexplained, butexclude the possibility that another infectious pathogens
such as herpes simplex type I and hepatitis A virus, which may be due to lower CRP values in our patients. The me-
dian CRP level in this study was 0.13 mg/dL and rangedplay a role for the development of atherosclerosis [42, 43],
might be involved in the increment of circulating IL-6. from 0.00 to 16.0 mg/dL; only 32 of all of the patients
(20.4%) had CRP values more than the normal rangeOur findings were based on a single measurement of
IL-6 from blood generally collected in the morning or (0.50 mg/dL) due to our selection of stable outpatients.
In contrast, a higher prevalence of raised CRP was no-afternoon. However, the intra-class correlation coefficient
was demonstrated as 0.87 for plasma IL-6 levels that were ticed in about one- to two-thirds of the HD patients in
the previous studies [8, 9]. In addition, we determinedmeasured eight times over 36 days, suggesting stability
for at least one month [44]. CRP by laser nephelometer, which is much less sensitive
under lower ranges. Since the risk of coronary heart dis-In this study, we could not find an exact reason why
circulating IL-6 was much higher in HD patients com- ease increases already with CRP values above 0.15 mg/dL
in patients with normal renal function [52], an additionalpared to age-matched control subjects. Neither smoking
habits nor gender affected circulating IL-6 levels in our assessment is needed to clarify the contribution of low-
grade inflammation to the severity of atherosclerosispatients. Disabled patients also were excluded because
disability is associated with a greater IL-6 level [45]. The more clearly using by a sensitive ELISA assay of CRP.
In our study, diabetes became a significant determi-increase in IL-6 is probably due to the stimulation in
production by HD procedure, because uremic patients nant for aortic calcification but not carotid artery thick-
ness. There was no significant difference in IMT betweenwith peritoneal dialysis or without dialysis showed no such
high level [46]. Recently, a significant increase in circulat- diabetic (0.66  0.04 mm) and non-diabetic (0.62 
0.01 mm) patients, which is in agreement with previousing IL-6 was observed at the end of HD in patients using
cellulose membrane but not polysulfone membrane, sug- studies also showed no difference in the severity of IMT
or IMarea between diabetic and non-diabetic uremicgesting that characteristics of the dialyzer membrane
may affect the production of IL-6 during an HD session patients [3, 4]. Since log IL-6 was positively correlated
with IMarea in diabetic patients, IL-6 may play a putative[47]. In contrast, it is unlikely that dialysate contamina-
tion may stimulate IL-6 production in this study, because role for the advance of carotid atherosclerosis even in
diabetic HD patients.the dialysate endotoxin levels were decreased to below
20 EU/L by the removal filter. In addition, the dialysis- The limitation of this work is that it is a cross-sectional
study. Carotid atherosclerosis advances slowly, and ath-related uremic or oxidative state may further increase
the IL-6 level, since IL-6 was positively correlated with erosclerotic lesions change over a long period. A recent
study showed that the rate of IMT progression becametime on HD treatment as described previously [15].
In a normal population, a higher expression of TNF- significant in a general population of patients seroposi-
tive to Chlamydia pneumoniae after following them formRNA is demonstrated in carotid plaque samples ob-
tained from symptomatic patients compared to asymp- at least three years [19]. A long-term longitudinal pro-
spective study is needed to explore the exact role oftomatic patients [48]. TNF- also promotes in vitro vas-
cular calcification [49]. In the present study, we found chlamydial infection on the advance of increased carotid
wall thickness in dialysis patients.that circulating log TNF- was correlated with the sever-
ity of IMT, IMarea and %ACI, respectively. However, In summary, we demonstrated that an elevation of
IL-6 was associated with carotid atherosclerosis in HDthere was no significant association between the serum
sTNFR p55 value, a sensitive marker for the TNF- patients. Blood log IL-6 levels were positively correlated
with anti-chlamydial antibody titers. In addition, serumsystem, and the degree of carotid wall thickness and
aortic wall calcification. Since the severity of ischemic titers of IgA antibody were correlated with the maximal
diameter of carotid plaque. These findings suggest thatarterial disease is reported not to be associated with circu-
lating sTNFR p55 and p75 levels in a population of gen- persistent chlamydial infection may stimulate, in part,
IL-6 production, which subsequently may facilitate theeral subjects [50], the role of TNF- for atherosclerosis
may be less in dialysis patients. In addition, serum titers atherogenic processes in HD patients.
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